Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 

Investorideas podcasts on iTunes, Google Play Music and potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts crypto corner    Play by Play – the latest sports headlines and sports stock news


Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Emerald Scientific Proficiency Tests Approved for Colorado Regulatory Compliance in #Cannabis Testing


SAN LUIS OBISPO, Calif. - September 22, 2017 ( Newswire) The Emerald Test, a program initiated by Emerald Scientific to improve cannabis testing laboratory performance since 2014 was recently approved in Colorado as a third party provider for the proficiency testing program for licensed testing facilities. Colorado is one of many states to require proficiency testing in order for cannabis laboratories to be certified to conduct required testing of cannabis products for quality, content and consumer safety. The contract was awarded after an extensive evaluation process conducted by the Department of Revenue, Marijuana Enforcement Division to determine which applicants were best able to meet the rigorous performance standards required for compliance with regulatory expectations for proficiency testing.

As states develop regulations to improve cannabis consumer safety, proficiency testing is becoming a linchpin to the determination of laboratory fitness. Proficiency testing is used to measure how accurately laboratories perform, and is used in many industries such as food safety and forensic testing as a critical tool for quality assurance. The Emerald Test program measures the accuracy of individual labs as well as comparing their results to other labs for indicators of variability and performance improvement. The Emerald Test "meets the audit criteria for the proficiency test participation requirement for the accreditation" according to one ISO 17025 accreditation provider. The proficiency test is a key component of quality assurance, which is a major requirement for labs seeking ISO 17025 accreditation.

Held twice yearly, The Emerald Test is a proficiency test and an inter-laboratory comparison (ILC-PT), allowing data to be collected pertaining to the performance of laboratories on a national scale. Testing labs across the United States are signing up for the Fall 2017 Emerald Test ILC/PT in an effort to advance quality assurance in the industry, meet regulatory requirements and achieve ISO 17025 accreditation. Cannabis testing labs can enroll in the Fall Emerald Test beginning September 25th to participate. Go to the The Emerald Test website for additional information.

Media contact:

Ken Groggel
877-567-3598 x 709

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Watch the 420 Cannabis Investor video

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy: